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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S266locomotion. Ccr2 null mice were protected from these locomotion
decreases, despite similar joint damage at 8 weeks post DMM, and
Ccr2 null DRG did not produce MCP-1. Therefore, we sought to further
investigate the expression and regulation of MCP-1 in the DMM
model. The current goals were to: 1) Test whether TNF-a induces
MCP-1 production in DRG cells, since it has been shown that TNF-
a induces Mcp-1 mRNA in cultured DRG cell lines. 2) Analyze MCP-1
protein content in the knees of wild-type (WT) and Ccr2 null mice after
DMM.
Methods: Knee-innervating DRG, L3-L5, were collected from 10-week
old naïve C57BL/6 WT or Ccr2 null mice. Cells were isolated and
cultured for 2 days in basal medium before 48 h-stimulation with 0, 25,
or 100 ng/mL TNF-a; supernatants were collected for MCP-1 ELISA. Hip
cartilage explants were harvested from 5-week old naove C57BL/6mice.
Hip cartilage was used since it is not possible to culture mouse knee
cartilage explants. Explants were rested overnight, stimulated with 100
ng/mL TNF-a for 48 h, and supernatants were collected for MCP-1 ELISA.
DMM or sham surgery was performed in the right knees of 10-week old
male C57BL/6 WT or Ccr2 null (Taconic #3736) mice. At 0, 4, and 8
weeks after surgery, whole knee joints were extracted for ELISA. At 4 or
8 weeks post surgery, DRG cells were cultured for 4 days and super-
natants collected for ELISA.
Results: In order to test whether TNF-a is able to stimulate primary DRG
cells to produce MCP-1 protein, we treated naïve WT DRG cells with
TNF-a. Cultures stimulated with 25 ng/mL TNF-a produced 37-fold
increased amounts of MCP-1 compared to unstimulated cells
(p<0.0001); a higher concentration of 100 ng/mL TNF-a did not further
increase MCP-1. This conﬁrms earlier reports of increased Mcp-1 mRNA
following TNF-a stimulation. DRG cells from naïve Ccr2 null mice
responded in the same way to TNF-a.
We looked for the presence of TNF-a in cultures of DRG cells taken from
WT or Ccr2 null naïve, sham, or DMM mice at 4 and 8 weeks post
surgery. None of these cultures contained measurable amounts of
TNF-a.
Next, we determined MCP-1 levels in whole knee joint extracts after
DMM inWT and Ccr2 null mice. In WT, knee MCP-1 protein levels were
elevated 4 weeks post DMM, compared to sham and naïve age-matched
controls (p<0.0001); by 8 weeks post DMM, levels had returned to
baseline. MCP-1 was also increased in knee extracts from Ccr2 null
mice, 4 weeks after DMM, but to a lesser extent than in WT. In order to
determine the potential source of MCP-1 in the knee, we began by
testing whether cartilage is able to produce MCP-1. Cartilage explants
stimulated with 100 ng/mL TNF-a produced 86-fold increased levels of
MCP-1 compared to unstimulated explants (p¼0.0008). When we
looked for the presence of TNF-a in knee extracts, however, we found
that DMM and naïve extracts contained similar low levels of TNF-a at 4
and 8 weeks post surgery. TNF-a levels in Ccr2 null knee extracts
mirrored the WT results, with no difference at 4 or 8 weeks between
DMM and naïve extracts.
Conclusions: These observations conﬁrm that TNF-a can stimulate DRG
neurons and cartilage explants to produce MCP-1 protein, conﬁrming
previous reports that TNF-a induces MCP-1 mRNA in these tissues. We
did not, however, detect elevated TNF-a levels in the DRG or in the knee
joint in situ in the DMM model at 4 or 8 weeks post surgery. It is
possible that TNF-a upregulation occurs at earlier time points than the
ones studied here (McNamee et al 2010 reported TNF-a mRNA in the
knee at 3 days post DMM) or that other factors are driving MCP-1
production.
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Purpose: The prevalence of type 3 ﬁngerlength pattern, determined by
a shorter 4th digit compared to the 2nd digit, is inﬂuenced by prenatal
androgen exposure and has been studied previously as a biomarker for
gender differences in the risk of several traits. Osteoarthritis (OA) and
chronic musculoskeletal pain are both sexually dimorphic. In this study,
we evaluate the association of ﬁngerlength type, as a marker of prenatal
androgen exposure, with the risk of osteoarthritis (OA) and chronic
musculoskeletal pain.Methods: Fingerlength pattern was determined in a total of 4784
participants of the prospective cohort Rotterdam Study II and III. Hand
X-rays were visually classiﬁed in three different ﬁngerlength pattern
types. Logistic regression was used to analyze the association of type 3
ﬁngerlength pattern with radiological OA of the hip, knee and hand. A
meta-analysis of previous published studies and our results was per-
formed to evaluate the association with kneeOA. Subsequently, we
studied the association of type 3 ﬁngerlength pattern with chronic
musculoskeletal pain.
Results: Participants with type 3 ﬁngerlength pattern had a 64%
increased risk for having handOA (OR 1.64; P-value 1.06*10-7). This
ﬁnding was independent of the severity of the disease. No associations
with knee- or hipOAwere found. The meta-analysis of kneeOA and type
3 ﬁngerlength pattern showed no evidence for association, however
large heterogeneity was observed, which was probably driven by
differences in the OA phenotype deﬁnition. Only studies that had
a clinical deﬁnition, deﬁned by both structural damage to the knee and
pain, showed an association between knee OA and ﬁngerlength
patterns. We therefore examined whether type 3 ﬁngerlength pattern
was associated with chronic joint pain and, we indeed observed that
individuals with a lower 2D:4D ratio had 41% more risk for having joint
pain (OR 1.41; P-value 1.4*10-3).
Conclusions: Type 3 ﬁngerlength pattern is associated with handOA,
indicating prenatal androgens to contribute to the development of this
disease. We additionally observed an association between low 2D:24
ratio and the risk for joint pain. Since prenatal androgens inﬂuences
both the development of ﬁngerlength pattern and the brain, a devel-
opmental cerebral susceptibility for chronic musculoskeletal pain may
underlie the association found with type 3 ﬁngerlength pattern.
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Purpose: A number of pro-inﬂammatory and catabolic changes are
observed during the progression of osteoarthritis. However, the rela-
tionship between these changes, the molecular events that regulate
these changes, and the development of painful symptoms is incom-
pletely understood. Many of the pro-inﬂammatory and catabolic
pathways rely on the downstream effects of NF-lB activity, a key
transcription factor involved in regulating inﬂammation. This study
utilized non-invasive in vivo luminescence imaging of NF-lB activity
and simultaneous measures of pain sensitivities in a mouse model of
inﬂammatory arthritis to test for relationships between NF-lB activity
and pain.
Methods: Transgenic mice engineered to carry cDNA for luciferase
downstream of NF-kB response elements were acquired for this study
(n¼24, BALB/C-Tg(NF kB-RE-luc), age 7-8 weeks, Taconic). Mice
received a 5 uL intra-articular injection of normal saline (n¼12) or 10
mg/ml monoiodoacetate (MIA, n¼12). A subset of mice (n¼6/group;
MIA, Saline) were sacriﬁced on day 3 post injection with the remaining
mice being sacriﬁced on day 28 post injection. Mice underwent in vivo
imaging of luminescence to measure NF-lB activity (IVIS100, Caliper)
preoperatively and at intervals from day 1 to 28; mice also underwent
tactile allodynia and incapacitance meter testing at these same time-
points to measure a threshold for paw withdrawal from mechanical
stimuli and weight bearing, respectively. The knees were saved for
histology at time of sacriﬁce.
Results: MIA injection induced arthritic changes in the NF-lB reporter
transgenic mouse model including NF-lB activity, joint degradation,
and the development of pain sensitivities. NF-lB activity was signiﬁ-
cantly increased in the knee ROI after injection on days 1 and 3
compared to preoperative values, and on day 3 when compared to
saline injection (p<0.05, 2-way ANOVA, Tukey Post Hoc) (Fig. 1a,b). The
50% withdrawal threshold was signiﬁcantly decreased for MIA injection
on days 3 and 7 compared to preoperative values, and signiﬁcantly
decreased on days 3, 7, 21, and 28 when compared to saline injection
(p<0.05, 2-way ANOVA, Tukey Post Hoc) (Fig. 1c). Weight distribution
signiﬁcantly shifted to the contralateral limb for MIA injection animals
on days 3 and 7 when compared to pre-operative values (p<0.05) and
on day 3 when compared to Saline injection (p<0.05) (Fig. 1d). A
